ghk-cu clinical trial human randomized 2026: Benefits, Mechanisms, Safety & Evidence The Human Tripeptide GHK-Cu in
Description
Other copper metabolism disorders similarly contraindicate GHK-Cu use
Growth and energy support
Leukopenia, macrocytosis, and thrombocytopenia occur in young adults with Down syndrome
Those with persistent fatigue or high stress may benefit from biweekly doses
Clinical Trial Dosing Ranges Dose Titration Schedules Clinical trials have employed gradual dose escalation to minimize gastrointestinal side effects [9] : Standard Titration Protocol (Example from ONWARDS 1) Rationale: Gradual titration allows tolerance development to gastrointestinal effects (particularly nausea) while building up to therapeutic doses
